| The BioMart community portal: an innovative alternative to large, centralized data repositories D Smedley, S Haider, S Durinck, L Pandini, P Provero, J Allen, O Arnaiz, ... Nucleic acids research 43 (W1), W589-W598, 2015 | 795 | 2015 |
| Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence RC Coombes, K Page, R Salari, RK Hastings, A Armstrong, S Ahmed, ... Clinical Cancer Research 25 (14), 4255-4263, 2019 | 376 | 2019 |
| Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high circulating tumor cell counts JA Shaw, DS Guttery, A Hills, D Fernandez-Garcia, K Page, BM Rosales, ... Clinical Cancer Research 23 (1), 88-96, 2017 | 223 | 2017 |
| GWAS Central: a comprehensive resource for the comparison and interrogation of genome-wide association studies T Beck, RK Hastings, S Gollapudi, RC Free, AJ Brookes European journal of human genetics 22 (7), 949-952, 2014 | 205 | 2014 |
| Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor–Positive Metastatic Breast Cancer DS Guttery, K Page, A Hills, L Woodley, SD Marchese, B Rghebi, ... Clinical chemistry 61 (7), 974-982, 2015 | 185 | 2015 |
| Epigenetic control of retrotransposon expression in human embryonic stem cells A Macia, M Munoz-Lopez, JL Cortes, RK Hastings, S Morell, ... Molecular and cellular biology 31 (2), 300-316, 2011 | 159 | 2011 |
| Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer D Fernandez-Garcia, A Hills, K Page, RK Hastings, B Toghill, KS Goddard, ... Breast Cancer Research 21, 1-13, 2019 | 116 | 2019 |
| Cell-free DNA analysis in current cancer clinical trials: a review M Cisneros-Villanueva, L Hidalgo-Pérez, M Rios-Romero, ... British journal of cancer 126 (3), 391-400, 2022 | 100 | 2022 |
| Next generation sequencing of circulating cell-free DNA for evaluating mutations and gene amplification in metastatic breast cancer K Page, DS Guttery, D Fernandez-Garcia, A Hills, RK Hastings, J Luo, ... Clinical chemistry 63 (2), 532-541, 2017 | 95 | 2017 |
| HGVbaseG2P: a central genetic association database GA Thorisson, O Lancaster, RC Free, RK Hastings, P Sarmah, D Dash, ... Nucleic acids research 37 (suppl_1), D797-D802, 2009 | 88 | 2009 |
| Early detection of residual breast cancer through a robust, scalable and personalized analysis of circulating tumour DNA (ctDNA) antedates overt metastatic recurrence RC Coombes, A Armstrong, S Ahmed, K Page, RK Hastings, R Salari, ... Cancer Res 79, P4-01, 2019 | 59 | 2019 |
| Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer P Adamo, CM Cowley, CP Neal, V Mistry, K Page, AR Dennison, ... Oncotarget 8 (50), 87221, 2017 | 50 | 2017 |
| Circulating tumour-derived DNA in metastatic soft tissue sarcoma NC Eastley, B Ottolini, R Neumann, JL Luo, RK Hastings, I Khan, ... Oncotarget 9 (12), 10549, 2018 | 36 | 2018 |
| Circulating tumor DNA profiling from breast cancer screening through to metastatic disease K Page, LJ Martinson, D Fernandez-Garcia, A Hills, KLT Gleason, ... JCO Precision Oncology 5, 1768-1776, 2021 | 16 | 2021 |
| Inclusion of multiple high‐risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma M Sereno, Z He, CR Smith, J Baena, M Das, RK Hastings, G Rake, ... Histopathology 78 (6), 838-848, 2021 | 13 | 2021 |
| Longitudinal whole-exome sequencing of cell-free DNA for tracking the co-evolutionary tumor and immune evasion dynamics: longitudinal data from a single patient RK Hastings, MR Openshaw, M Vazquez, AB Moreno-Cardenas, ... Annals of Oncology 32 (5), 681-684, 2021 | 10 | 2021 |
| The circulating nucleic acid characteristics of non-metastatic soft tissue sarcoma patients N Eastley, A Sommer, B Ottolini, R Neumann, JL Luo, RK Hastings, ... International journal of molecular sciences 21 (12), 4483, 2020 | 9 | 2020 |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer D Fernandez-Garcia, G Nteliopoulos, RK Hastings, A Rushton, K Page, ... British Journal of Cancer 127 (10), 1858-1864, 2022 | 4 | 2022 |
| MA12. 05 phase 1 study of HSP90 inhibitor ganetespib with pemetrexed and cisplatin/carboplatin chemotherapy for pleural mesothelioma D Fennell, S Danson, M Forster, D Talbot, P Woll, J Child, Y Ngai, ... Journal of Thoracic Oncology 13 (10), S397, 2018 | 4 | 2018 |
| Prevalence of ctDNA in early screen-detected breast cancers using highly sensitive and specific dual molecular barcoded personalised mutation assays K Page, LJ Martinson, RK Hastings, D Fernandez-Garcia, KLT Gleason, ... Annals of Oncology 32 (8), 1057-1060, 2021 | 3 | 2021 |
